NCT00365599: Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer |
|
|
| Completed | 2 | 43 | US | suberoylanilide hydroxamic acid (SAHA, Vorinostat), SAHA, Vorinostat, NSC #701852, tamoxifen citrate (Tamoxifen), Nolvadex, Tam, Tamoxifen | H. Lee Moffitt Cancer Center and Research Institute, Merck Sharp & Dohme LLC | Breast Cancer | 04/11 | 08/12 | | |
NCT00818649: Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia |
|
|
| Terminated | 2 | 16 | US | bortezomib, Velcade, vorinostat, suberoylanilide hydroxamic acid (SAHA) | Masonic Cancer Center, University of Minnesota, Merck Sharp & Dohme LLC, Millennium Pharmaceuticals, Inc. | Leukemia, Myelodysplastic Syndrome | 05/12 | 05/12 | | |
